Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain

2024-10-1

Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?

2024-10-1

Therapeutic innovations for geographic atrophy: A promising horizon

2024-10-1

Editorial Board

2024-9-12

Role of specific CDKs in regulating DNA damage repair responses and replication stress

2024-9-1

Preoperative optimization: Review on nutritional assessment and strategies in IBD

2024-8-1

Editorial Board

2024-8-1

Drug effects on neuropeptides and their receptors: Big hopes but moderate success in the treatment of chronic pain

2024-8-1

Pharmacological regulation of HIF-1α, RGC death, and glaucoma

2024-8-1

Modulating regulatory T cell migration in the treatment of autoimmunity and autoinflammation

2024-8-1

Effects of protein glycation and protective mechanisms against glycative stress

2024-6-1

Advanced therapeutic approaches in sarcoglycanopathies

2024-6-1

Biased signalling in analgesic research and development

2024-6-1

Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer

2024-6-1

Editorial Board

2024-6-1

The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis

2024-6-1

Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration

2024-5-23

Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”

2024-5-18

In the heart and beyond: Mitochondrial dysfunction in heart failure with preserved ejection fraction (HFpEF)

2024-5-16

From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling

2024-4-17

Novel treatments for dry eye syndrome

2024-4-1

Lipid raft disruption as an opportunity for peripheral analgesia

2024-4-1

Editorial overview: New and revitalized old targets in metabolic disease

2024-4-1

Editorial Board

2024-4-1

Analgesic potential of voltage gated sodium channel modulators for the management of pain

2024-4-1

Editorial overview: Endocrine and metabolic diseases (2023)

2024-4-1

Targeting TRP channels for pain relief: A review of current evidence from bench to bedside

2024-3-11

Estrogen related receptor alpha: Potential modulator of age-related macular degeneration

2024-3-5

Targeting the endocannabinoid system for the management of low back pain

2024-2-23

Gastrointestinal issue: Advances in gastrointestinal oncology

2024-2-23

Optic nerve regeneration: Potential treatment approaches

2024-2-1

Editorial Board

2024-2-1

Integrating network pharmacology: The next-generation approach in ocular drug discovery

2024-2-1

Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction

2024-2-1

Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review

2024-2-1

Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drug

2024-2-1

Targeting ferroptosis in the maintenance of mitochondrial homeostasis in the realm of septic cardiomyopathy

2024-2-1

Editorial overview: “Purinergic immune cell regulation reveals novel pharmacological targets”

2024-1-25

AI-driven GPCR analysis, engineering, and targeting

2024-1-12

Interventional functional diagnostics in gastrointestinal endoscopy: Combining diagnostic and therapeutic tools in the endoscopy suite with the functional lumen imaging probe

2023-12-1

Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation

2023-12-1

Editorial Board

2023-12-1

Pharmacologic treatment of gastroparesis: What is (still) on the horizon?

2023-10-1

Discerning conformational dynamics and binding kinetics of GPCRs by 19F NMR

2023-10-1

The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-2

2023-9-19

Editorial Board

2023-9-15

Illuminating GPCR signaling mechanisms by NMR spectroscopy with stable-isotope labeled receptors

2023-8-21

Corrigendum to “Antihypertensive effect of soybean bioactive peptides: A review” [Curr Opin Pharmacol (62) (2022) 74–81]

2023-8-1

Central and peripheral mechanisms involved in the control of GnRH neuronal function by metabolic factors

2023-8-1

Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle

2023-8-1